Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | esterase, putative | 0.0222 | 0.3217 | 1 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0222 | 0.3217 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0222 | 0.3217 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0222 | 0.3217 | 1 |
Schistosoma mansoni | amidase | 0.055 | 1 | 1 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.055 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0222 | 0.3217 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.02 | 0.2768 | 0.2768 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0222 | 0.3217 | 0.5 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0066 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0222 | 0.3217 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0222 | 0.3217 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.055 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0222 | 0.3217 | 0.5 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0222 | 0.3217 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0137 | 0.1458 | 0.1458 |
Plasmodium falciparum | lysophospholipase, putative | 0.0222 | 0.3217 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.02 | 0.2768 | 0.2768 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0222 | 0.3217 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.055 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0222 | 0.3217 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0222 | 0.3217 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.055 | 1 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0222 | 0.3217 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0222 | 0.3217 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.02 | 0.2768 | 0.2768 |
Plasmodium falciparum | lysophospholipase, putative | 0.0222 | 0.3217 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0222 | 0.3217 | 1 |
Mycobacterium ulcerans | lysophospholipase | 0.0222 | 0.3217 | 1 |
Plasmodium vivax | PST-A protein | 0.0222 | 0.3217 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0222 | 0.3217 | 0.5 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0066 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0137 | 0.1458 | 0.1458 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.055 | 1 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0222 | 0.3217 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0137 | 0.1458 | 0.1458 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0066 | 0 | 0.5 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0222 | 0.3217 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.02 | 0.2768 | 0.2768 |
Loa Loa (eye worm) | hypothetical protein | 0.055 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 2 ug ml-1 | Antibacterial activity against Staphylococcus aureus UC 9218 | ChEMBL. | 17350254 |
MIC (functional) | = 32 ug ml-1 | Antibacterial activity against Staphylococcus aureus UC 9218 in presence of 10% human serum | ChEMBL. | 17350254 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.